O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer

• Päätekijät: Lixia Zhou (Tekijä), Huiqin Wu (Tekijä), Xingli Bai (Tekijä), Shuyun Min (Tekijä), Jiawen Zhang (Tekijä), Cunli Li (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Identification of novel biomarkers is helpful for the diagnosis and treatment of cervical cancer. Mucin glycosylating enzyme GALNT2 modulates mucin O-glycosylation, and has been revealed as a regulator of tumorigenesis in various cancers. However, the expression pattern of GALNT2 in cervical cancer...